The FDA has approved Gilead’s remdesivir; presidential nominees debate health care reforms; US endorses international antiabortion declaration.
The FDA approved Gilead’s remdesivir as the first drug to treat coronavirus disease 2019 (COVID-19), according to Politico. The decision is based on 3 randomized trials that found the drug can reduce the length of hospital stays among those infected and reduce the likelihood that patients will require oxygen. However, none of the trials concluded that remdesivir can reduce the risk of death, and a multicountry trial backed by the World Health Organization (WHO) found the drug showed “little to no effect” on hospitalized patients. The FDA did not mention this trial in its risk-benefit assessment for the drug and stated that a trial by the National Institutes of Health, one of the 3 supporting the approval, was better suited to assess a time to recovery than the WHO-backed trial.
During the final presidential debate prior to the November 3 general election, former Vice President Joe Biden and President Donald Trump argued over health care reforms as the nation continues to suffer from the COVID-19 pandemic. Trump accused Biden of talking about socialized medicine with his proposed expansion of the Affordable Care Act (ACA), which the former vice president dubbed “Bidencare,” USA Today reports. In response to the jab, Biden argued that his plan would reduce drug prices and premiums by allowing for drug price negotiation through the Medicare program. If the ACA is overturned, Trump said he would come up with a brand new health care plan, although few details of such a plan have been revealed.
The United States, along with Brazil, Egypt, Hungary, Indonesia and Uganda, cosponsored a nonbinding international antiabortion declaration Thursday, The Washington Post reports. The move is a rebuke to United Nations human rights bodies that seek to protect abortion access around the globe. Both Secretary of State Mike Pompeo and HHS secretary Alex Azar participated in the signing of the Geneva Consensus Declaration, which aims to promote women’s health. Abortion access is widely restricted in the other countries that cosponsored the declaration. Specifically, the consensus formalizes a coalition opposed to the United Nations’ Universal Declaration of Human Rights, a declaration that US allies like Britain and France support.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More